For: | Ghasemi F, Rostami S, Meshkat Z. Progress in the development of vaccines for hepatitis C virus infection. World J Gastroenterol 2015; 21(42): 11984-12002 [PMID: 26576087 DOI: 10.3748/wjg.v21.i42.11984] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i42/11984.htm |
Number | Citing Articles |
1 |
Simona Georgescu, Mircea Tampa, Madalina Mitran, Cristina Mitran, Maria Sarbu, Ilinca Nicolae, Clara Matei, Constantin Caruntu, Monica Neagu, Mircea Popa. Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection (Review). Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6987
|
2 |
Muriel Lavie, Xavier Hanoulle, Jean Dubuisson. Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00910
|
3 |
Alimuddin Zumla, Martin Rao, Robert S Wallis, Stefan H E Kaufmann, Roxana Rustomjee, Peter Mwaba, Cris Vilaplana, Dorothy Yeboah-Manu, Jeremiah Chakaya, Giuseppe Ippolito, Esam Azhar, Michael Hoelscher, Markus Maeurer. Host-directed therapies for infectious diseases: current status, recent progress, and future prospects. The Lancet Infectious Diseases 2016; 16(4): e47 doi: 10.1016/S1473-3099(16)00078-5
|
4 |
Mohammad Moradi, Farzad Mozafari, Shirin Hosseini, Rouhullah Rafiee, Faezeh Ghasemi. A concise review on impacts of microRNAs in biology and medicine of hepatitis C virus. Gene Reports 2020; 20: 100761 doi: 10.1016/j.genrep.2020.100761
|
5 |
Devanathan Reka, Chandrashekaran Girish. Plant-based vaccines against viral hepatitis: A panoptic review. World Journal of Virology 2024; 13(3): 97162 doi: 10.5501/wjv.v13.i3.97162
|
6 |
Armina Alagheband Bahrami, Mojgan Bandehpour, Bahram Kazemi, Mahmood Bozorgmehr, Nariman Mosaffa, Rouzbeh Chegeni. Assessment of a poly-epitope candidate vaccine against Hepatitis B, C, and poliovirus in interaction with monocyte-derived dendritic cells: An ex-vivo study. Human Immunology 2020; 81(5): 218 doi: 10.1016/j.humimm.2020.02.010
|
7 |
María Q. Marín, Patricia Pérez, Carmen E. Gómez, Carlos Óscar S. Sorzano, Mariano Esteban, Juan García-Arriaza. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression. Viruses 2018; 10(8): 414 doi: 10.3390/v10080414
|
8 |
Ying Yang, Feng-Ping Wu, Wen-Jun Wang, Juan-Juan Shi, Ya-Ping Li, Xin Zhang, Shuang-Suo Dang. Real life efficacy and safety of direct-acting antiviral therapy for treatment of patients infected with hepatitis C virus genotypes 1, 2 and 3 in northwest China. World Journal of Gastroenterology 2019; 25(44): 6551-6560 doi: 10.3748/wjg.v25.i44.6551
|
9 |
Krupa R. Mysore, Daniel H. Leung. Hepatitis B and C. Clinics in Liver Disease 2018; 22(4): 703 doi: 10.1016/j.cld.2018.06.002
|
10 |
Samaneh Karimkhanilouyi, Saeid Ghorbian. Nucleic acid vaccines for hepatitis B and C virus. Infection, Genetics and Evolution 2019; 75: 103968 doi: 10.1016/j.meegid.2019.103968
|
11 |
Deepa S. Mandlik, Satish K. Mandlik. An Overview of Hepatocellular Carcinoma with Emphasis on Dietary Products and Herbal Remedies. Nutrition and Cancer 2022; 74(5): 1549 doi: 10.1080/01635581.2021.1965630
|
12 |
Ashraf Tabll, Reem El-Shenawy, Yasmine El Abd. Update on Hepatitis C. 2017; doi: 10.5772/intechopen.70649
|
13 |
Amir Atapour, Pooneh Mokarram, Zohreh MostafaviPour, Seyed Younes Hosseini, Younes Ghasemi, Shiva Mohammadi, Navid Nezafat. Designing a Fusion Protein Vaccine Against HCV: An In Silico Approach. International Journal of Peptide Research and Therapeutics 2019; 25(3): 861 doi: 10.1007/s10989-018-9735-4
|
14 |
Eva Torres-Sangiao, Alina Holban, Monica Gestal. Advanced Nanobiomaterials: Vaccines, Diagnosis and Treatment of Infectious Diseases. Molecules 2016; 21(7): 867 doi: 10.3390/molecules21070867
|
15 |
Zhenqiu Liu, Xianhua Mao, Yanfeng Jiang, Ning Cai, Li Jin, Tiejun Zhang, Xingdong Chen. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China. Cancer Medicine 2019; 8(12): 5787 doi: 10.1002/cam4.2477
|
16 |
Antoni Sureda, Miquel Martorell, Xavier Capó, Margalida Monserrat-Mesquida, Maria Magdalena Quetglas-Llabrés, Mahsa Rasekhian, Seyed M. Nabavi, Silvia Tejada. Antitumor Effects of Triterpenes in Hepatocellular Carcinoma. Current Medicinal Chemistry 2021; 28(13): 2465 doi: 10.2174/0929867327666200602132000
|
17 |
Santa Olivera, Angel Perez, Viviana Falcon, Dioslaida Urquiza, Dagmara Pichardo, Gillian Martinez-Donato. Protective cellular immune response against hepatitis C virus elicited by chimeric protein formulations in BALB/c mice. Archives of Virology 2020; 165(3): 593 doi: 10.1007/s00705-019-04464-x
|
18 |
Qing Xie, Jian-Wei Xuan, Hong Tang, Xiao-Guang Ye, Peng Xu, I-Heng Lee, Shan-Lian Hu. Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China. World Journal of Hepatology 2019; 11(5): 421-441 doi: 10.4254/wjh.v11.i5.421
|
19 |
Sina Alizadeh, Shiva Irani, Azam Bolhassani, Seyed Mehdi Sadat. Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responses. Immunology Letters 2019; 212: 70 doi: 10.1016/j.imlet.2019.06.011
|
20 |
Muhammad Shoaib Akhtar. Recent approaches in clinical trials of hepatitis C virus vaccine, challenges and future directions. Asia-Pacific Journal of Oncology 2024; doi: 10.32948/ajpt.2024.09.24
|
21 |
María Q. Marín, Patricia Pérez, Karl Ljungberg, Carlos Óscar S. Sorzano, Carmen E. Gómez, Peter Liljeström, Mariano Esteban, Juan García-Arriaza, J.-H. James Ou. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV. Journal of Virology 2019; 93(7) doi: 10.1128/JVI.00055-19
|
22 |
Ahmed A. Ali, Ashraf A. Tabll. Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine development. Virology 2025; 602: 110307 doi: 10.1016/j.virol.2024.110307
|
23 |
Marianna Zając, Izabela Muszalska, Agnieszka Sobczak, Adrianna Dadej, Szymon Tomczak, Anna Jelińska. Hepatitis C – New drugs and treatment prospects. European Journal of Medicinal Chemistry 2019; 165: 225 doi: 10.1016/j.ejmech.2019.01.025
|
24 |
Emmanuelle V. LeBlanc, Youjin Kim, Chantelle J. Capicciotti, Che C. Colpitts. Hepatitis C Virus Glycan-Dependent Interactions and the Potential for Novel Preventative Strategies. Pathogens 2021; 10(6): 685 doi: 10.3390/pathogens10060685
|
25 |
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. Journal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
|
26 |
Reza Taherkhani, Fatemeh Farshadpour. Global elimination of hepatitis C virus infection: Progresses and the remaining challenges. World Journal of Hepatology 2017; 9(33): 1239-1252 doi: 10.4254/wjh.v9.i33.1239
|
27 |
A.A. Khryanin, A.V. Sokolovskaia, V.K. Bocharova. Lichen planus associated with viral hepatitis C: new data, concepts and hypotheses. Klinicheskaya dermatologiya i venerologiya 2023; 22(4): 426 doi: 10.17116/klinderma202322041426
|
28 |
Arthi Venkatesan, Febin Prabhu Dass J.. Review on chemogenomic approaches towards hepatitis C viral targets. Journal of Cellular Biochemistry 2019; 120(8): 12167 doi: 10.1002/jcb.28581
|
29 |
Ke-Qin Hu, Wei Cui, Susan D Rouster, Kenneth E Sherman. Hepatitis C virus antigens enzyme immunoassay for one-step diagnosis of hepatitis C virus coinfection in human immunodeficiency virus infected individuals. World Journal of Hepatology 2019; 11(5): 442-449 doi: 10.4254/wjh.v11.i5.442
|
30 |
Vignan Manne, John Ryan, Jonathan Wong, Gayatri Vengayil, Syed Abdul Basit, Robert G. Gish. Hepatitis C Vaccination: Where We Are and Where We Need to Be. Pathogens 2021; 10(12): 1619 doi: 10.3390/pathogens10121619
|